Telix Pharmaceuticals Limited (ASX:TLX)
Australia
· Delayed Price · Currency is AUD 14.97
+0.23 (1.53%)
Apr 29, 2026, 11:59 AM AEST
Telix Pharmaceuticals Market Cap
Telix Pharmaceuticals has a market cap or net worth of 5.00 billion as of April 28, 2026. Its market cap has decreased by -43.88% in one year.
Market Cap
5.00B
Enterprise Value
5.49B
Revenue
1.21B
Ranking
n/a
PE Ratio
n/a
Stock Price
14.97
Market Cap Chart
Since November 15, 2017, Telix Pharmaceuticals's market cap has increased from 152.03M to 5.00B, an increase of 3,187.93%. That is a compound annual growth rate of 51.15%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Mesoblast | 2.77B |
| Neuren Pharmaceuticals | 1.56B |
| PYC Therapeutics | 1.27B |
| Clarity Pharmaceuticals | 1.16B |
| Opthea | 738.77M |
| Racura Oncology | 517.08M |
| Clinuvel Pharmaceuticals | 455.87M |
| CSL Limited | 62.31B |